The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8987302 B1

PDF
Full Text
Expired
Date of Patent:
Mar. 24, 2015

Filed:

Dec. 26, 2012
Applicants:

Panmed Ltd., Beersel, BE;

Genoscience Pharma Sas, Marseilles, FR;

Inventor:

Philippe Halfon, Marseilles, FR;

Assignees:

Panmed Ltd., Beersel, BE;

Genoscience Pharma SAS, Marseilles, FR;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/47 (2006.01); A61K 31/4706 (2006.01); A61K 31/7056 (2006.01); A61K 38/21 (2006.01); A61K 45/06 (2006.01);
U.S. Cl.
CPC ...
A61K 31/4706 (2013.01); A61K 31/7056 (2013.01); A61K 38/212 (2013.01); A61K 45/06 (2013.01);
Abstract

Methods of treating a hepatitis C virus (HCV) related disease, such as HCV infections in subjects non-responsive to anti-HCV therapy, are described herein, comprising administering to the subject a therapeutically effective amount of hydroxychloroquine. An antiviral agent may be co-administered with the hydroxychloroquine. Methods utilizing synergistic combinations of hydroxychloroquine and an antiviral agent are disclosed. Further disclosed are compositions comprising hydroxychloroquine and an antiviral agent, as well as hydroxychloroquine and uses thereof for the treatment of a hepatitis C virus (HCV) related disease.


Find Patent Forward Citations

Loading…